2023 is set to be a year of transition for behavioral health, as the COVID-era public health emergency (PHE) comes to an end and economic headwinds impact the global economy.
2022 didn’t turn out to be the blockbuster M&A year of 2021. But with so much fragmentation in the behavioral health industry, there is still plenty of opportunity.
This is particularly true when it comes to digital behavioral health companies, many of which faced a number of setbacks last year.
Companies that took advantage of the PHE’s relaxed regulations will finally get some answers to looming questions about their business model as the federal government comes out with more permanent regulations around telehealth and medication assisted treatment (MAT), Behavioral Health Business reports.
And while it appears the feds may be loosening certain regulations, expect some watchdogs to keep a close eye on digital companies dealing with controlled substances. Previously, digital health companies Cerebral and Done came under scrutiny for their prescribing practices – and that heat hasn’t cooled. Read more.
